Wikipedia:WikiProject Chemicals/Chembox validation/VerifiedDataSandbox and 4-HO-DBT: Difference between pages
(Difference between pages)
Content deleted Content added
Saving copy of the {{drugbox}} taken from revid 474643111 of page 4-HO-DBT for the Chem/Drugbox validation project (updated: 'CAS_number'). |
added Category:Hydroxyarenes using HotCat |
||
| Line 1: | Line 1: | ||
{{Short description|Chemical compound}} |
|||
{{ambox | text = This page contains a copy of the infobox ({{tl|drugbox}}) taken from revid [{{fullurl:4-HO-DBT|oldid=474643111}} 474643111] of page [[4-HO-DBT]] with values updated to verified values.}} |
|||
{{Drugbox |
{{Drugbox |
||
| Verifiedfields = changed |
|||
| verifiedrevid = |
| verifiedrevid = |
||
| IUPAC_name = ''N''-Butyl-''N''-[2-(4-hydroxy-1''H''-indol-3-yl)ethyl]butan-1-amine |
| IUPAC_name = ''N''-Butyl-''N''-[2-(4-hydroxy-1''H''-indol-3-yl)ethyl]butan-1-amine |
||
| image = 4-HO-DBT.svg |
| image = 4-HO-DBT.svg |
||
<!--Clinical data--> |
<!--Clinical data--> |
||
| tradename = |
| tradename = |
||
| Line 16: | Line 16: | ||
| legal_status = |
| legal_status = |
||
| routes_of_administration = |
| routes_of_administration = |
||
<!--Pharmacokinetic data--> |
<!--Pharmacokinetic data--> |
||
| bioavailability = |
| bioavailability = |
||
| Line 23: | Line 22: | ||
| elimination_half-life = |
| elimination_half-life = |
||
| excretion = |
| excretion = |
||
<!--Identifiers--> |
<!--Identifiers--> |
||
| CAS_number_Ref = {{cascite|changed|??}} |
|||
| CAS_number = |
| CAS_number = 63065-89-4 |
||
| ATC_prefix = |
| ATC_prefix = |
||
| ATC_suffix = |
| ATC_suffix = |
||
| UNII_Ref = {{fdacite|correct|FDA}} |
|||
| ⚫ | |||
| UNII = R3EY4G4BLQ |
|||
| ⚫ | |||
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} |
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} |
||
| ChemSpiderID = 10579818 |
| ChemSpiderID = 10579818 |
||
<!--Chemical data--> |
<!--Chemical data--> |
||
| C=18 | H=28 | N=2 | O=1 |
| C=18 | H=28 | N=2 | O=1 |
||
| ⚫ | |||
| molecular_weight = 288.44 g/mol |
|||
| ⚫ | |||
| InChI = 1/C18H28N2O/c1-3-5-11-20(12-6-4-2)13-10-15-14-19-16-8-7-9-17(21)18(15)16/h7-9,14,19,21H,3-6,10-13H2,1-2H3 |
|||
| InChIKey = BDOJPNJIBDXWQQ-UHFFFAOYAI |
|||
| StdInChI_Ref = {{stdinchicite|correct|chemspider}} |
| StdInChI_Ref = {{stdinchicite|correct|chemspider}} |
||
| StdInChI = 1S/C18H28N2O/c1-3-5-11-20(12-6-4-2)13-10-15-14-19-16-8-7-9-17(21)18(15)16/h7-9,14,19,21H,3-6,10-13H2,1-2H3 |
| StdInChI = 1S/C18H28N2O/c1-3-5-11-20(12-6-4-2)13-10-15-14-19-16-8-7-9-17(21)18(15)16/h7-9,14,19,21H,3-6,10-13H2,1-2H3 |
||
| Line 45: | Line 42: | ||
| melting_high = 75 |
| melting_high = 75 |
||
}} |
}} |
||
'''4-Hydroxy-''N,N''-dibutyltryptamine''' ('''4-HO-DBT''') is a [[Psychedelics, Dissociatives and Deliriants|psychedelic]] [[psychoactive drug|drug]] belonging to the [[tryptamine]] family. It is found either as its [[crystalline]] [[hydrochloride]] [[salt (chemistry)|salt]] or as an oily or crystalline [[base (chemistry)|base]]. 4-HO-DBT was first made by the chemist [[Alexander Shulgin]] and reported in his book [[TiHKAL]]. Shulgin reported a dosage of 20 mg orally to be without effects. However this compound has subsequently been sold as a "[[research chemical]]" and anecdotal reports suggest that at higher doses 4-HO-DBT is indeed an active hallucinogen, although somewhat weaker than other similar tryptamine derivatives. |
|||
Several different isomers of this compound could be made (see [[Dibutyltryptamine|DBT]] for a fuller discussion) but of these only the isobutyl isomer 4-HO-DIBT was synthesised by Shulgin (mp 152-154 °C) and was also found to be inactive at a 20 mg dose. |
|||
==External links== |
|||
* [http://www.erowid.org/library/books_online/tihkal/tihkal15.shtml TiHKAL entry] |
|||
* [http://tihkal.info/read.php?domain=tk&id=15 4-HO-DBT entry in TiHKAL • info] |
|||
{{Hallucinogenic tryptamines}} |
|||
{{Tryptamines}} |
|||
[[Category:Psychedelic tryptamines]] |
|||
[[Category:Hydroxyarenes]] |
|||
{{hallucinogen-stub}} |
|||